Karyopharm Therapeutics, Inc. will be removed from NASDAQ Biotechnology Index.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.02 USD | -7.27% | -5.56% | +17.92% |
05-08 | Earnings Flash (KPTI) KARYOPHARM THERAPEUTICS Reports Q1 Revenue $33.1M, vs. Street Est of $34.5M | MT |
05-08 | Transcript : Karyopharm Therapeutics Inc., Q1 2024 Earnings Call, May 08, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.92% | 128M | |
+2.93% | 106B | |
+7.02% | 23.47B | |
-14.60% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-8.83% | 16.78B | |
+5.51% | 14.41B | |
+37.49% | 12.86B | |
+329.39% | 8.78B |
- Stock Market
- Equities
- KPTI Stock
- News Karyopharm Therapeutics Inc.
- Karyopharm Therapeutics Inc.(NasdaqGS: KPTI) dropped from NASDAQ Biotechnology Index